Inovio Pharmaceuticals (INO) Change in Acquisitions & Divestments (2016 - 2025)
Inovio Pharmaceuticals (INO) has disclosed Change in Acquisitions & Divestments for 16 consecutive years, with -$14.2 million as the latest value for Q4 2025.
- Quarterly Change in Acquisitions & Divestments fell 304.42% to -$14.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, down 96.18% year-over-year, with the annual reading at $5.0 million for FY2025, 96.18% down from the prior year.
- Change in Acquisitions & Divestments hit -$14.2 million in Q4 2025 for Inovio Pharmaceuticals, down from $8.9 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $123.1 million in Q1 2022 to a low of -$14.2 million in Q4 2025.
- Historically, Change in Acquisitions & Divestments has averaged $47.8 million across 5 years, with a median of $43.9 million in 2023.
- Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 24293.23% in 2022 and later plummeted 304.42% in 2025.
- Year by year, Change in Acquisitions & Divestments stood at $34.6 million in 2021, then soared by 186.23% to $99.1 million in 2022, then tumbled by 50.56% to $49.0 million in 2023, then plummeted by 85.83% to $6.9 million in 2024, then tumbled by 304.42% to -$14.2 million in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for INO at -$14.2 million in Q4 2025, $8.9 million in Q3 2025, and $10.3 million in Q2 2025.